Oncology & Cancer
Lipiodol: From intrusion until exile from the tumor microenvironment
An editorial paper has been published in Oncoscience titled, "Lipiodol: from intrusion until exile from the tumor microenvironment."
Jan 8, 2024
0
0
Hepatocellular Carcinoma
Oncology & Cancer
AI offers promise for earlier and more accurate hepatocellular carcinoma diagnosis
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. It is a major global health concern with rising rates, particularly in North Africa and East Asia. Although potentially curable in the early stages, ...
Dec 29, 2023
0
4
Oncology & Cancer
Mailed orders found to double liver cancer screening rates
Liver cancer screening among patients with cirrhosis almost doubled when they were mailed a signed order from their specialist, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. ...
Dec 22, 2023
0
0
Oncology & Cancer
Scientists find gene therapy reduces liver cancer in animal model
Researchers at UC Davis Comprehensive Cancer Center have shown that inhibiting a specific protein using gene therapy can shrink hepatocellular carcinoma (HCC) in mice. Silencing the galectin 1 (Gal1) protein, which is often ...
Nov 30, 2023
0
0
Oncology & Cancer
Enhanced treatment of liver carcinoma with a drug-eluting hydrogel
Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed an injectable or catheter-administered hydrogel with enhanced capabilities for treating hepatocellular carcinoma (HCC), a deadly form ...
Nov 29, 2023
0
0
Oncology & Cancer
Researchers look to improve early identification of liver cancer
An overwhelming majority of hepatocellular carcinoma occurs in people already suffering from cirrhosis of the liver.
Nov 14, 2023
0
0
Medical research
Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients
An international randomized controlled trial, advised by a steering committee co-led by a senior clinician-scientist from the National Cancer Centre Singapore and Duke-NUS Medical School, Singapore, has reported that the ...
Oct 23, 2023
0
0
Oncology & Cancer
Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial finds
A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study ...
Oct 22, 2023
0
0
Oncology & Cancer
New treatment trialed in mice offers hope for advanced liver cancer
Researchers have discovered a new way to treat hepatocellular carcinoma (HCC) the most common type of liver cancer, and the third leading cause of cancer death worldwide.
Sep 26, 2023
0
0
Oncology & Cancer
A calculator to predict benefit from adjuvant transarterial chemoembolization for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most commonly diagnosed cancer of the liver and the fourth leading cause of cancer-related mortality worldwide, with China accounting for over half of the global annual cases and deaths. ...
Aug 22, 2023
0
12
